5%
Original price was: $200.00.$190.00Current price is: $190.00.
Retatrutide is a triple agonist targeting GLP-1, GIP and glucagon receptors, developed for the management of obesity and significant weight reduction. Administered by subcutaneous injection, it combines anorexigenic effects, improved insulin sensitivity and increased energy metabolism. Clinical trials have shown marked weight losses greater than those observed with current treatments, positioning retatrutide as a promising option for the medical management of obesity.
⚠️Important note
Each product must be mixed with bacteriostatic water. A Free 3ml bottle is included with every purchase.
Description
Retatrutide is a triple agonist targeting GLP-1, GIP and glucagon receptors, developed for the management of obesity and significant weight reduction. Administered by subcutaneous injection, it combines anorexigenic effects, improved insulin sensitivity and increased energy metabolism. Clinical trials have shown marked weight losses greater than those observed with current treatments, positioning retatrutide as a promising option for the medical management of obesity.
Key features:
- triple agonist — GLP-1 / GIP / glucagon receptor
- Route: subcutaneous injection (weekly protocols)
- Indications: management of obesity and weight reduction
- Expected effects: strong appetite reduction, loss of fat mass, metabolic
- improvement (insulin sensitivity), increased energy metabolism
Customer benefits:
- Substantial weight loss, potentially greater than current agents
- Improvement in metabolic parameters associated with obesity
- Potential improvement in quality of life related to weight reduction
Storage
| Before reconstitution: | After reconstitution: |
|---|---|
| -Temperature: generally -20°C (frozen) -Protect from light and moisture; keep vial tightly closed -Avoid repeated freeze/thaw cycles |
-Temperature: usually 2-8 °C, protected from light -Do not freeze the reconstituted solution |
2 reviews for Retatrutide 30 MG
There are no reviews yet.